News & Analysis on Clinical Trial Services & Contract Research And Development
Industry groups PhRMA, BIO and GPhA are petitioning the Supreme Court to overturn a local law that requires pharma companies to cough up payment for safe disposal of medicines which make their way to one county.
The top five CROs will increase their market share as pharma continues to up both R&D spending and outsourcing, according to Icon.
update
The US FDA has rejected Pharmexcil claims it no longer informs Indian regulators of manufacturing plant inspections and said its policy is to invite host-country inspectors to attend visits.
Synthetic paclitaxel production methods can support expanding market and new indications according to market analysis group.
Quintiles subsidiary Novella Clinical and the academic research arm of the Cardiovascular Research Foundation (CRF) are collaborating to offer pre-clinical to post-market trial services to developers of cardiovascular drugs and devices.
2015 is the year that AMRI loses its royalties for discovering the API of Allegra and the company is now looking to its string of recent acquisitions and new contract revenue to offset the loss.
Lonza signed a flurry of biopharma-related deals and launched a number of drug industry services in the final quarter of 2014 as its efforts to focus on pharma intensified.
Critical solvents used by the pharmaceutical manufacturers have been excluded from the EPA's final ruling on waste disposal, in a move welcomed by a US industry group.